Last update 07 Nov 2024

Dapagliflozin/Sitagliptin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dapagliflozin propanediol monohydrate/Sitagliptin phosphate monohydrate, Dapagliflozin/Sitagliptin Phosphate, DW6012
+ [2]
Target
DPP-4 x SGLT2
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
DONG WHA PHARM Co., Ltd.DONG WHA PHARM Co., Ltd.
Active Organization
AstraZeneca Pty Ltd.DONG WHA PHARM Co., Ltd.DONG WHA PHARM Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
KR (26 May 2023),
Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H35ClO9
InChIKeyGOADIQFWSVMMRJ-UPGAGZFNSA-N
CAS Registry960404-48-2
View All Structures (2)

Related

3
Clinical Trials associated with Dapagliflozin/Sitagliptin
NCT05453786 / CompletedPhase 1
A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics After Administration of SID1903 (Fixed-dose Combination) or Loose Combination in Healthy Adult Volunteers
NCT05266404 / CompletedPhase 1
A Randomized, 2-period, 2-treatment, Single-dose, Crossover Study to Assess the Bioequivalence of the Fixed Dose Combination (FDC) of Dapagliflozin 10 mg and Sitagliptin 100 mg, and Dapagliflozin 10 mg and Sitagliptin 100 mg Administered as Individual Tablets in Healthy Subjects
NCT05236998 / CompletedPhase 1
A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics After Administration of SID1903 (Fixed-dose Combination of Dapagliflozin and Sitagliptin) or Loose Combination in Healthy Adult Volunteers
100 Clinical Results associated with Dapagliflozin/Sitagliptin
Login to view more data
100 Translational Medicine associated with Dapagliflozin/Sitagliptin
Login to view more data
100 Patents (Medical) associated with Dapagliflozin/Sitagliptin
Login to view more data
100 Deals associated with Dapagliflozin/Sitagliptin
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
KR
DONG WHA PHARM Co., Ltd.DONG WHA PHARM Co., Ltd.
26 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free